Certified by Founder Lodge
Ampersand Biomedicines
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $65,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powe
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 26 ,2025 | Series B | $65,000,000 |
Eli Lilly and Company
Flagship Pioneering
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
BuildVision | $10,000,000 | (Mar 28, 2025)
Nanoprecise Sci Corp | $38,000,000 | (Mar 28, 2025)
Mendel | $35,000,000 | (Mar 28, 2025)
MemryX Inc. | $44,000,000 | (Mar 28, 2025)
Galatea Bio Inc. | $25,000,000 | (Mar 28, 2025)
